CD8A and non-small cell lung carcinoma: In contrast, taurolithocholic acid (TLCA) promotes CD8+ T cell activation and cytokine production, and has been associated with improved ICI response in non-small cell lung cancer, possibly via enhanced memory CD8+ T cell formation (68).